Open AccessA narrative review of adjuvant therapy for glioma: hyperbaric oxygen therapy
Author(s) -
Tao Xue,
Jiasheng Ding,
Bing Li,
Demao Cao,
Gang Chen
Publication year - 2021
Publication title -
medical gas research
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.52
H-Index - 24
ISSN - 2045-9912
DOI - 10.4103/2045-9912.318861
Subject(s) - medicine , radiation therapy , hyperbaric oxygen , neurosurgery , adjuvant therapy , glioma , chemotherapy , adjuvant , surgery , oncology , cancer research
Glioma is a kind of common malignant tumor in neurosurgery and has a high mortality and morbidity rate, which poses a serious threat to the health of people all over the world. Surgery is the preferred treatment for patients with glioma, radiotherapy or chemotherapy can be used after surgery. Although there are clear therapeutic protocols, the efficacy and safety of these protocols are clinically proven, a large number of patients are still dissatisfied with the treatment and the health of the patient remains unsatisfactory. Therefore, it is crucial to look for other treatments or complementary treatments. In the modern medical treatment, hyperbaric oxygen (HBO) therapy is widely used in various kinds of pathological state of adjuvant therapy, and existing studies confirm the efficacy of HBO therapy in combination with surgery, radiotherapy, chemotherapy, and photodynamic therapy. Studies have shown that HBO can inhibit the growth of tumor tissue as an adjunctive therapy. This provides novel insights into the clinical treatment of glioma patients. Although HBO is not licensed for use in cancer treatment, as a kind of adjuvant therapy, the treatment effect of HBO can be accepted by the patients and its cost lower, which could be regarded as an ideal safe treatment.